Icon of the Instituts for Quality and Efficiency in Health Care

Report

Glitazones in the treatment of diabetes mellitus type 2

Status
Status: Commission completed
Project no.
A05-05A
Last updated

Report documents

  1. Executive summary of the final report

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 155 kB, EN, not accessible
    Download file : Executive summary of the final report (PDF document, 155 kB, EN, not accessible)

  2. Final report

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 4 MB, DE, not accessible
    Download file : Final report (PDF document, 4 MB, DE, not accessible)

  3. Documentation and appraisal of comments on the preliminary report

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 2 MB, DE, not accessible
    Download file : Documentation and appraisal of comments on the preliminary report (PDF document, 2 MB, DE, not accessible)

  4. Preliminary report

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 3 MB, DE, not accessible
    Download file : Preliminary report (PDF document, 3 MB, DE, not accessible)

  5. Report plan version 2.0

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 227 kB, DE, not accessible
    Download file : Report plan version 2.0 (PDF document, 227 kB, DE, not accessible)

  6. Documentation and appraisal of comments on the report plan version 1.0

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 5 MB, DE, not accessible
    Download file : Documentation and appraisal of comments on the report plan version 1.0 (PDF document, 5 MB, DE, not accessible)

  7. Amendment 3 to the report plan version 1.0

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 51 kB, DE, not accessible
    Download file : Amendment 3 to the report plan version 1.0 (PDF document, 51 kB, DE, not accessible)

  8. Amendment 2 to the report plan version 1.0

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 121 kB, DE, not accessible
    Download file : Amendment 2 to the report plan version 1.0 (PDF document, 121 kB, DE, not accessible)

  9. Amendment 1 to the report plan version 1.0

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 32 kB, DE, not accessible
    Download file : Amendment 1 to the report plan version 1.0 (PDF document, 32 kB, DE, not accessible)

  10. Report plan version 1.0

    Glitazones in the treatment of diabetes mellitus type 2

    published on
    Document type
    PDF document, 163 kB, DE, not accessible
    Download file : Report plan version 1.0 (PDF document, 163 kB, DE, not accessible)

Press releases

Glitazones have not yet been sufficiently investigated

No long-term studies on rosiglitazone available / Pioglitazone could reduce risk of late vascular complications but increase risk of heart failure
Press release

Additional information

IQWiG health information

What medications help in type 2 diabetes?

Project details

Project no.
A05-05A
Commission
Commission awarded on 22.02.2005 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Digestion, metabolism and hormones

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page